Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...

Sen. Mike Yakawich, R-Billings, sits in the Senate Agriculture Committee on Feb. 4, 2025. Yakawich’s Senate Bill 112, banning government purchase of opioid antagonists from companies who contributed ...

The U.S. Postal Service began to allow inbound mail and packages from China and Hong Kong Posts on Wednesday, less than 24 ...

University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

A wrongful death lawsuit claims a Scranton woman died from a product containing kratom, a botanical native to Southeast Asia.

Plus: A new non-opioid painkiller, the wave of lawsuits against Trump EOs, a key vote for RFK Jr., a big radiopharma deal and ...

Authorities arrested a 70-year-old Carrollton man last week after uncovering an illegal opioid distribution operation from ...

Pain medication sold at Walmart in at least 41 states is being recalled across the country due to a manufacturing error that ...

Federal lawmakers are trying once again to push for a study on the “overmedication” of veterans by Department of Veterans ...

What is Fentanyl? How does it enter the U.S.? Why is it a sticking point in relations between U.S., China, Canada and Mexico?

Robert F. Kennedy Jr.’s HHS nomination moves to a full Senate vote; Donald Trump’s tariff war sparks China-related concerns for biopharma; Pfizer, Merck and more announce Q4 and 2024 earnings; and the ...